SOUTH SAN FRANCISCO, Calif., May 5, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc.
(Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company
developing novel therapeutics to treat cancer and eye diseases, will report
first quarter 2010 results on Tuesday, May 11, 2010. A conference call and
webcast hosted by OXiGENE management will begin at 4:30 p.m. EDT (1:30 a.m.
PDT).
To listen to a live or archived version of the audio webcast, please log on to
the Company's website, www.oxigene.com. Under the "Investor" tab, select the
link to "Events and Presentations."
OXiGENE's earnings conference call can also be heard live by dialing (888)
841-3431 in the United States and Canada, and (678) 809-1060 for international
callers, five minutes prior to the beginning of the call. A replay will be
available starting at 7:30 pm, EDT (4:30 pm, PDT) on May 11, 2010 and ending at
12:00 midnight EDT (9:00 p.m., PDT) on Tuesday, May 25, 2010. To access the
replay, please dial (800) 642-1687 if calling from the United States or Canada,
or (706) 645-9291 from international locations. Please refer to replay pass
code 73237663.
About OXiGENE
OXiGENE is a clinical-stage biopharmaceutical company developing novel
therapeutics to treat cancer and eye diseases. The Company's major focus is
developing vascular disrupting agents (VDAs) that selectively disrupt abnormal
blood vessels associated with solid tumor progression and visual impairment.
OXiGENE is dedicated to leveraging its intellectual property and therapeutic
development expertise to bring life-extending and life-enhancing medicines to
patients.
The OXiGENE, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=4969
CONTACT: OXiGENE, Inc.
Investor and Media Contact:
Michelle Edwards, Investor Relations
650-635-7006
medwards@oxigene.com
OXiGENE Announces First Quarter 2010 Earnings Conference Call and Webcast
| Source: Oxigene, Inc.
Attachments
